Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci

Vancomycin-resistant enterococci (VRE) account for a large proportion of hospital-acquired infections. Determining optimal treatment of VRE urinary tract infections (UTIs) is challenging. The purpose of this study was to determine if a difference in efficacy or safety exists between linezolid and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Wingler, Mary Joyce, Patel, Neel R., King, S. Travis, Wagner, Jamie L., Barber, Katie E., Stover, Kayla R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628880/
https://www.ncbi.nlm.nih.gov/pubmed/34842791
http://dx.doi.org/10.3390/pharmacy9040175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628880/
https://www.ncbi.nlm.nih.gov/pubmed/34842791
http://dx.doi.org/10.3390/pharmacy9040175

Ejemplares similares